PDC is calculated as (number of days covered) / (total days in the time period) Cohorts and Time Horizons The second phase of analysis extends and refines the original analysis by separating cohorts by primary indication: Diabetes cohort: Individuals with a diabetes indication and GLP-1 use primarily for glycemic control Weight loss cohort: Individuals using GLP-1s for obesity or weight management without a diabetes indication Extending observation periods 30-month analysis window for the diabetes cohort 18-month analysis window for the weight loss cohort This approach allows us to evaluate whether the cost and clinical trends seen in the first white paper persist over a longer timeframe and whether they hold consistently across key sub populations
Furthermore, they have assisted in the development of animal models and chemicals that have the potential to modify diseases that are currently being developed for clinical evaluation
More large long-term RCTs with respiratory disease as the primary outcome are needed in the future to evaluate the link between the incidence of respiratory disease and GLP-1 receptor agonists
Prasad, K.N., C, C., Karthik, Y., Girish, G.V
Each box provides 30 servings in a delicious orange vanilla flavour for improved compliance Unit of Measure above: Each 10mL serving Glycerin, almond butter, phosphatidylcholine, medium chain triglycerides, d-alpha tocopherol, oleic acid, natural vanilla flavour, natural orange flavour, cinnamon, clove oil, stevia
Crit Rev Food Sci Nutr 59(3):506527
